Geopolitics Alpha

How Ingredion aims to capitalize on ‘reformulation boom’ with Tate & Lyle deal

Published . Updated .

The acquisition is set to position Ingredion as the "go-to provider for texture and healthful solutions" within the food and beverage industries, according to its CEO.

Directly affected

  • INGR Ingredion

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    A fund of health-care companies

  • XBI SPDR S&P Biotech

    A fund of biotechnology companies

  • UNH UnitedHealth

    A large health insurer

  • JNJ Johnson & Johnson

    A large health-care company

  • LLY Eli Lilly

    A large drug maker

  • PFE Pfizer

    A large drug maker

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
INGR———————
XLV———————
XBI———————
UNH———————
JNJ———————
LLY———————
PFE———————

The acquisition is set to position Ingredion as the "go-to provider for texture and healthful solutions" within the food and beverage industries, according to its CEO.

Source: Food Dive

Ingredion (INGR) since this story, compared with the market

Since the first closing price after “How Ingredion aims to capitalize on ‘reformulation boom’ with Tate & Lyle deal,” Ingredion (INGR) is -0.99%. The S&P 500 fund (SPY) is +0.65% over the same days, a -1.65% difference versus the market.

INGR
SPY

Who gains and who loses around Ingredion (INGR)

Companies tied to this story

  • INGR Ingredion

    In “How Ingredion aims to capitalize on ‘reformulation boom’ with Tate & Lyle deal,” Ingredion (INGR) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names INGREDION INC in the headline; GA resolved that company to INGR

Ingredion (INGR)

The 17 Sep 2026 story “How Ingredion aims to capitalize on ‘reformulation boom’ with Tate & Lyle deal” names Ingredion (INGR) because of this story.

Ingredion (INGR) is on the page because The reported development directly names INGREDION INC in the headline; GA resolved that company to INGR

Price levels for Ingredion (INGR)

INGR traded between 93.71 and 99.79 across 20 sessions. The latest close on file is 96.30.

A simple score for Ingredion (INGR)

14 out of 100

“How Ingredion aims to capitalize on ‘reformulation boom’ with Tate & Lyle deal” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.